We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 975 results
  1. The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors

    Antipsychotic drugs are the mainstay of treatment for schizophrenia and provide adjunct therapies for other prevalent psychiatric conditions,...

    Rachel E. Hardy, Injae Chung, ... Kenneth R. Pryde in Biology Direct
    Article Open access 01 August 2023
  2. Use of Naïve Bayes Classifier to Assess the Effects of Antipsychotic Agents on Brain Electrical Activity Parameters in Rats

    Abstract

    Research and development of novel methods to determine the effects of antipsychotic agents is an important challenge for...

    Yu. I. Sysoev, D. D. Shits, ... S. V. Okovityi in Journal of Evolutionary Biochemistry and Physiology
    Article 01 July 2022
  3. Molecular Features Triggered by Antipsychotic Medication in Brain Cells

    Treating schizophrenia is a challenge currently handled with the use of antipsychotic drugs. Despite being the most applied treatment strategy,...
    Lívia Ramos-da-Silva, André S. L. M. Antunes in Neuroproteomics as a Tool for Understanding Schizophrenia
    Chapter 2022
  4. Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

    Vesicular monoamine transporter 2 (VMAT2) is responsible for packing monoamine neurotransmitters into synaptic vesicles for storage and subsequent...

    Svein Isungset Støve, Åge Aleksander Skjevik, ... Aurora Martinez in Communications Biology
    Article Open access 23 November 2022
  5. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis

    Renal cell carcinoma (RCC) is one of the most lethal genitourinary malignancies with poor prognoses, since it is largely resistant to chemotherapy,...

    Min-Che Tung, Yung-Wei Lin, ... Ming-Hsien Chien in Cell Death & Disease
    Article Open access 23 April 2022
  6. Drug Repurposing: An Effective Tool in Modern Drug Discovery

    Abstract

    Drug repurposing is using an existing drug for a new treatment that was not indicated before. It has received immense attention during the...

    V. S. Kulkarni, V. Alagarsamy, ... S. Murugesan in Russian Journal of Bioorganic Chemistry
    Article 21 February 2023
  7. In Silico Pharmacology and Drug Repurposing Approaches

    Drug repurposing is an innovative and resourceful approach to expanding access to treatment options by making new uses for medications that are...
    Ghanshyam Parmar, Jay Mukesh Chudasama, ... Ashish Patel in CADD and Informatics in Drug Discovery
    Chapter 2023
  8. Drug repurposing strategy II: from approved drugs to agri-fungicide leads

    Epidemic diseases of crops caused by fungi deeply affected the course of human history and processed a major restriction on social and economic...

    Jun-**a An, Yue Ma, ... Ying-Qian Liu in The Journal of Antibiotics
    Article 27 January 2023
  9. Drug Repurposing to Discover Novel Anti-Inflammatory Agents Inhibiting JAK3/STAT Signaling

    Abstract

    Among the JAKs, JAK3 is the most important target for the treatment of inflammatory diseases because its inhibition showed the utmost...

    S. Y. Sheikh, F. Hassan, ... M. Nasibullah in Russian Journal of Bioorganic Chemistry
    Article 28 July 2022
  10. A Platform for the Study of Drug Interactions and Adverse Effects Prediction

    This article reports on the development of a Web platform for the study of Adverse Drug Events (ADEs). The platform is able to import ADE episodes...
    Diogo Mendes, Rui Camacho in Bioinformatics and Biomedical Engineering
    Conference paper 2023
  11. Pharmacoencephalographic Assessment of Antiphyschotic Agents’ Effect Dose-Dependency in Rats

    Abstract

    Pharmacoencephalography (pharmaco-EEG) is a prominent instrument for the pharmacological screening of new psychoactive molecules. This...

    Yu. I. Sysoev, D. D. Shits, ... S. V. Okovityi in Journal of Evolutionary Biochemistry and Physiology
    Article 01 November 2023
  12. Current non-invasive strategies for brain drug delivery: overcoming blood–brain barrier transport

    Background

    The blood-brain barrier (BBB) is a complex and dynamic structure that serves as a gatekeeper, restricting the migrations of most compounds...

    **aoxiao Zheng, **gyao Yang, ... Jie Zhu in Molecular Biology Reports
    Article 21 December 2023
  13. Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment

    Background

    The Reelin (RELN) gene encodes the protein reelin, which is a large extracellular matrix glycoprotein that plays a key role in brain...

    Jiajun Yin, Yana Lu, ... Jianmin Yuan in Hereditas
    Article Open access 06 November 2020
  14. GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing

    Background

    The main focus of in silico drug repurposing, which is a promising area for using artificial intelligence in drug discovery, is the...

    Fan Zhang, Wei Hu, Yirong Liu in BMC Bioinformatics
    Article Open access 13 September 2022
  15. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia

    Introduction

    Olanzapine (OLA) is one of the most commonly used second-generation antipsychotics for the treatment of schizophrenia. However, the...

    Xuan Wang, Meihong **u, ... Fengchun Wu in Metabolomics
    Article 11 July 2022
  16. Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome

    Drug-induced long QT syndrome (diLQTS) is the phenomenon by which the administration of drugs causes prolongation of cardiac repolarisation and leads...

    Clifford TeBay, Adam P. Hill, Monique J. Windley in Biophysical Reviews
    Article Open access 27 January 2022
  17. Graph regularized non-negative matrix factorization with prior knowledge consistency constraint for drug–target interactions prediction

    Background

    Identifying drug–target interactions (DTIs) plays a key role in drug development. Traditional wet experiments to identify DTIs are...

    Junjun Zhang, Minzhu **e in BMC Bioinformatics
    Article Open access 29 December 2022
  18. SSELM-neg: spherical search-based extreme learning machine for drug–target interaction prediction

    Background

    The experimental verification of a drug discovery process is expensive and time-consuming. Therefore, efficiently and effectively...

    Lingzhi Hu, Chengzhou Fu, ... Deyu Tang in BMC Bioinformatics
    Article Open access 03 February 2023
  19. The endoplasmic reticulum participated in drug metabolic toxicity

    Covalent binding of reactive metabolites formed by drug metabolic activation with biological macromolecules is considered to be an important...

    Qingcai Huang, Youwen Chen, ... Yuanyan Liu in Cell Biology and Toxicology
    Article 18 January 2022
  20. Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads

    Phytopathogenic bacteria are a major cause of crop mortality and yield reduction, especially in field cultivation. The lack of effective chemistry...

    Yue Ma, Yi-Rong Wang, ... Ying-Qian Liu in The Journal of Antibiotics
    Article 14 October 2022
Did you find what you were looking for? Share feedback.